Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant trading activity in Advanced Medical Solutions Group plc (AMS.L) ordinary shares.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, a standard arrangement for firms operating as exempt principal traders under the Takeover Code framework.
The bank holds a notable advisory relationship with the company, as Investec is Advisor and Joint Broker to Advanced Medical Solutions Group plc.
The dealings were undertaken on 23rd June 2026, with the formal public disclosure submitted the following day on 24th June 2026.
On the purchase side, Investec handled 340,461 ordinary shares, with prices ranging from a low of 230 to a high of 240 per unit.
Sales activity was slightly larger, with 341,961 ordinary shares sold across the same price range of 230 to 240 per unit.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, options, or agreements that could serve as an inducement to deal or refrain from dealing in relation to this offer.
The bank also confirmed no agreements or understandings exist relating to voting rights or the future acquisition or disposal of any relevant securities referenced by derivatives.
The contact named in the disclosure is Priyali Bhattacharjee, reachable by telephone for any follow-up inquiries regarding the filing.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service for transparency during offer periods.
